|本期目录/Table of Contents|

[1]杨 钰,尹则琳,郑曰忠.葡萄膜炎继发高眼压或青光眼的诊治分析[J].天津医科大学学报,2017,23(03):270-273.
　YANG Yu,YIN Ze-lin,ZHENG Yue-zhong.Diagnosis and treatment of ocular hypertension or secondary glaucoma in uveitis[J].Journal of Tianjin Medical University,2017,23(03):270-273.
点击复制

葡萄膜炎继发高眼压或青光眼的诊治分析(PDF)
分享到：

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:
23卷
期数:
2017年03期
页码:
270-273
栏目:
临床医学
出版日期:
2017-05-18

文章信息/Info

Title:
Diagnosis and treatment of ocular hypertension or secondary glaucoma in uveitis
文章编号:
1006-8147(2017)03-0270-04
作者:
杨 钰1 ; 尹则琳2 ;  郑曰忠2
（1. 天津医科大学眼科临床学院葡萄膜病科 ， 天津 300020； 2. 天津市眼科医院葡萄膜病科 ，天津 300020）
Author(s):
YANG Yu1;  YIN Ze-lin2;  ZHENG Yue-zhong 2
(1. Department of Uveal Diseases , Clinical College of Ophthalmology , Tianjin Medical University, Tianjin 300020, China ；2. Department of Uveal Diseases ,Tianjin Eye Hospital, Tianjin 300020, China)
关键词:
葡萄膜炎;  继发性青光眼;  治疗方法
Keywords:
uveitis;  secondary glaucoma;  treatment
分类号:
R773
DOI:
-
文献标志码:
A
摘要:
目的：探讨葡萄膜炎患者继发眼压升高或青光眼的临床特点和诊治效果。方法： 收集葡萄膜炎继发眼压升高或青光眼患者158例（206眼）的临床资料，分析其抗青光眼药物、激光或手术治疗效果。结果：158例患者中，男86例，女72例；平均年龄（46.5±17.8）岁。其中行抗青光眼药物治疗99眼（48.1%），因瞳孔闭锁或膜闭行YAG激光虹膜切除术54眼（26.2%），睫状体光凝术20眼（9.7%），小梁切除术16眼（7.8%），小梁切除术联合白内障超声乳化和人工晶体植入术7眼（3.4%），引流阀植入手术4眼（1.9%），有6眼（2.9%）行多次联合手术治疗。随访6~18个月，眼压控制较好者181眼，成功率为87.9%。末次随访发现矫正视力提高者171眼（83.0%），视力稳定者28眼（13.6%），视力恶化者7眼（3.4%）。结论：对于葡萄膜炎继发青光眼患者应积极控制炎症和降低眼压，局部滴眼药物、激光虹膜切除术、滤过手术或青光眼引流阀植入术可很好地控制眼压，挽救患者视力。
Abstract:
?

Objective: To explore the clinical features and efficacy of treatment for the patients with ocular hypertension or glaucoma secondary to uveitis. Methods: There were 158 cases (206 eyes) of patients with ocular hypertension or glaucoma during the treatment of uveitis. The efficacy of treatment with topical or systemic anti-glaucoma medications, laser or surgical management was analyzed. Results: Among the 158 patients, there were 86 males and 72 females. The mean age was（46.5±17.8）years old. There were 99 eyes (48.1%) treated with anti-glaucoma medications, 54 eyes (26.2%) with YAG laser iridotomy, 20 eyes (9.7%) with cyclophotocoagulation, 16 eyes (7.8%) with trabeculectomy, 7 eyes (3.4%) with combined trabeculectomy and phacoemulsification and intraocular lens implantation, 4 eyes (1.9%) with glaucoma drainage implant, and 6 eyes (2.9%) with multiple surgical treatments. The intraocular pressure of 181 eyes was well controlled and the successful rate was 87.9% after the 12~18 months follow-up. The corrected visual acuity of 171 eyes (83.0%) was improved at last visit, 28 eyes (13.6%) were stable and 7 eyes (3.4%) were deteriorated. Conclusion: For the patients with ocular hypertension or glaucoma secondary to uveitis, the aggressive anti-inflammation and the anti-glaucoma medications are essential. Tropical drops, laser iridotomy, trabeculectomy, cyclophotocoagulation or glaucoma drainage implants could control the intraocular pressure and minimize the visual impairment.

参考文献/References:

[1] Siddique S S, Suelves A M, Baheti U, et al. Glaucoma and uveitis[J]. Surv Ophthalmol, 2013, 58（1）: 1

[2] Sayed M S, Lee R K. Current management approaches for uveitic glaucoma[J]. Int Ophthalmol Clin, 2015, 55（3）:141

[3] 郑曰忠, 时冀川. 葡萄膜炎继发青光眼的诊治进展[J]. 眼科研究, 2009, 27（5）: 437

[4] Herbert H M, Viswanathan A, Jackson H, et al. Risk factors for elevated intraocular pressure in uveitis[J]. J Glaucoma, 2004,13（2）: 96

[5] Yang P, Liu X, Zhou H, et al. Vogt-Koyanagi-Harada disease presenting as acute angle closure glaucoma at onset[J]. Clin Exp Ophthalmol, 2011, 39（7）:639

[6] Foster C S, Havrlikova K, Baltatzis S, et al. Secondary glaucoma in patients with juvenile rheumatoid arthritis associated iridocyclitis[J]. Acta Ophthalmol Scand, 2000, 78（5）:576

[7] Takahashi T, Ohtani S, Miyata K, et al. A clinical evaluation of uveitis-associated secondary glaucoma[J]. Jpn J Ophthalmol, 2002, 106（1）:39

[8] Sungur G K, Hazirolan D, Yalvac I S, et al. Incidence and prognosis of ocular hypertension secondary to viral uveitis[J]. Int Ophthalmol, 2010, 30（2）:191

[9] Shrestha S, Thapa M, Shah D N. Pattern of intraocular pressure fluctuation in uveitic eyes treated with corticosteroids[J]. Ocul Immunol Inflamm, 2014, 22（2）:110

[10] Hwang D K, Chou Y J, Pu C Y, et al. Risk factors for developing glaucoma among patients with uveitis: a nationwide study in Taiwan[J]. J Glaucoma, 2015, 24（3）:219

[11] Shimizu A, Maruyama K, Yokoyama Y, et al. Characteristics of uveitic glaucoma and evaluation of its surgical treatment[J]. Clin Ophthalmol, 2014, 8:2383

[12] Aman R, Engelhard S B, Bajwa A, et al. Ocular hypertension and hypotony as determinates of outcomes in uveitis[J]. Clin Ophthalmol, 2015,9:2291

[13] Markomichelakis N N, Kostakou A, Halkiadakis I, et al. Efficacy and safety of latanoprost in eyes with uveitic glaucoma[J]. Graefes Arch Clin Exp Ophthalmol, 2009, 247（6）:775

[14] 陈君毅, 孔祥梅, 孙兴怀. 选择性激光小梁成形术治疗糖皮质激素性青光眼的疗效观察[J]. 中国实验眼科杂志, 2014, 32（2）: 168

[15] 杨柳, 晏晓明, 聂红平, 等. 继发于葡萄膜炎的青光眼的手术治疗[J]. 中国实用眼科杂志, 2006, 24（2）: 198

[16] Al Obeidan S A, Osman E A, Mousa A, et al. Long-term evaluation of efficacy and safety of deep sclerectomy in uveitic glaucoma[J]. Ocul Immunol Inflamm, 2015,23（1）:82

[17] Carreno E, Villarón S, Portero A, et al. Surgical outcomes of uveitic glaucoma[J]. J Ophthalmol Inflamm Infect, 2011, 1（2）:43

[18] Voykov B, Deuter C, Zierhut M, et al. Is cyclophotocoagulation an option in the management of glaucoma secondary to Fuchs’ uveitis syndrome [J]. Graefes Arch Clin Exp Ophthalmol, 2014, 252（3）: 485

[19] Kalinina Ayuso V, Scheerlinck L M, de Boer J H. The effect of an Ahmed glaucoma valve implant on corneal endothelial cell density in children with glaucoma secondary to uveitis[J]. Am J Ophthalmol, 2013, 155（3）:530

[20] 周民稳, 王伟, 黄文彬, 等. 葡萄膜炎继发性青光眼与其他难治性青光眼Ahmed青光眼引流阀植入后前房反应的非随机对照研究[J]. 中华实验眼科杂志, 2015,33（3）:241

相似文献/References:

备注/Memo

备注/Memo:
作者简介 杨钰（1989-），女，硕士在读，研究方向：葡萄膜炎及相关免疫性眼病； 通信作者：郑曰忠， E-mail：eye2002@163.com。
更新日期/Last Update: 2017-05-18